Alpha Teknova, Inc. (TKNO) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US02080L1026
Alpha Teknova, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 40.52 m USD |
| Gross profit | 13.44 m USD |
| Operating income | -16.98 m USD |
| EBIT | -17.20 m USD |
| Net income | -17.26 m USD |
| Diluted EPS – continuing operations | -0.32 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Alpha Teknova, Inc.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
More stocks
- Smartgen (Zhengzhou) Technology Co. Ltd. A (301361.SZ)
- Baotek Industrial Materials Ltd (5340.TWO)
- NORTHRIM BANCORP INC (NRIM)
- ME Group International PLC (MEGP.L)
- Evolent Health, Inc. (EVH)
- AVITA Medical, Inc. (RCEL)
- Posti Group Oyj (POSTI.HE)
- Wuhan Kotei Informatics Co.Ltd. (301221.SZ)
- Guangdong Brandmax Marketing Co Ltd (300805.SZ)
- Singapore Post Ltd (S08.SI)
- GYRE THERAPEUTICS, INC. (GYRE)
- TELOS CORP (TLS)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.